The Luxembourg Competition Authority President rejects a request for interim measures in the context of the COVID-19 health crisis (Bionext / Laboratoire National de Santé)

I. Introduction On 17 December 2020, the President of the Luxembourg Competition Council (hereinafter the “President”) rendered a decision [1] on a request for interim measures requested by the laboratory Bionext S.A. (hereinafter “Bionext”) against the Laboratoire National de Santé (hereinafter “LNS”). This application is part of a main proceeding initiated by Bionext in relation to several potential abuses of dominant position taking place in the context of the Covid-19 health crisis. This is only the fourth decision on a request for interim measures rendered by the President of the Competition Council (hereinafter “the President”) since the beginning of the year 2008 [2]. This is the third decision by which the President refused to grant interim measures. Bionext may lodge an action for

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Bonn & Schmitt (Luxembourg)
  • Bonn & Schmitt (Luxembourg)

Quotation

Clémence Patte, Gabriel Bleser, The Luxembourg Competition Authority President rejects a request for interim measures in the context of the COVID-19 health crisis (Bionext / Laboratoire National de Santé), 17 December 2020, e-Competitions December 2020, Art. N° 98754

Visites 141

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues